Yogi Hale Hendlin, PhD; Jesse Elias, MA; Pamela M. Ling, MD, MPH
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Grant Support: By the National Cancer Institute at the National Institutes of Health (grants R01-CA141661 and R01-87472).
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-0759.
Requests for Single Reprints: Pamela M. Ling, MD, MPH, 530 Parnassus Avenue, Suite 366, University of California, San Francisco, San Francisco, CA 94143-1390; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. Hendlin and Ling and Mr. Elias: 530 Parnassus Avenue, Suite 366, University of California, San Francisco, San Francisco, CA 94143-1390.
Author Contributions: Conception and design: Y.H. Hendlin, J. Elias, P.M. Ling.
Analysis and interpretation of the data: Y.H. Hendlin, J. Elias, P.M. Ling.
Drafting of the article: Y.H. Hendlin, J. Elias.
Critical revision of the article for important intellectual content: Y.H. Hendlin, J. Elias, P.M. Ling.
Final approval of the article: Y.H. Hendlin, J. Elias, P.M. Ling.
Obtaining of funding: P.M. Ling.
Administrative, technical, or logistic support: Y.H. Hendlin, J. Elias, P.M. Ling.
Collection and assembly of data: Y.H. Hendlin, J. Elias.
Hendlin YH, Elias J, Ling PM. The Pharmaceuticalization of the Tobacco Industry. Ann Intern Med. ;167:278–280. doi: 10.7326/M17-0759
Download citation file:
Published: Ann Intern Med. 2017;167(4):278-280.
Published at www.annals.org on 18 July 2017
Cardiology, Coronary Risk Factors, Smoking, Tobacco, Alcohol, and Other Substance Abuse.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use